Press release
Geriatric Population Growth As A Key Driver Of The Chronic Disease Management Market: A Key Driver Powering Chronic Disease Management Market Growth In 2025
The Chronic Disease Management Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].What Is the Current Chronic Disease Management Market Size and Its Estimated Growth Rate?
The market size for managing chronic illnesses has seen considerable expansion in the past few years. Its value is projected to rise from $9.55 billion in 2024 to $11.36 billion in 2025, an annual growth rate of 19.0%. This growth over the historical period can be traced back to the use of data analytics for managing population health, educating patients for empowerment, implementing value-based care approaches, tailored treatment strategies, and an emphasis on preventive health care.
In the forthcoming years, it is anticipated that the market size for chronic disease management will experience significant expansion. The market is projected to reach $24.97 billion by 2029, with a compound annual growth rate (CAGR) of 21.8%. Contributory factors to this growth during the forecast period include the adoption of patient-centric care models, aging population, emphasis on remote patient monitoring (rpm), the rising occurrence of chronic diseases, and worldwide healthcare trends. Key trends to watch during this period are global health crises and pandemic responses, governmental initiatives and policy backing, the rise of consumer health applications and platforms, focus on the interchange and compatibility of health information, behavioral health attention, and the growth of telehealth.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6984
How Are Emerging Segments Shaping the Chronic Disease Management Market Landscape?
The chronic disease management market covered in this report is segmented -
1) By Service: Consulting Service, Implementation Service, Educational Service
2) By Delivery Mode: On-premise, Cloud-based, Web-based
3) By Disease Type: Cardiovascular Diseases, Diabetes, Cancer, Asthma, Chronic Obstructive Pulmonary Disorders
4) By End User: Providers, Payers
Subsegments:
1) By Consulting Service: Disease Management Assessment, Program Design And Development, Performance Evaluation
2) By Implementation Service: Technology Integration, Workflow Optimization, Care Coordination
3) By Educational Service: Patient Education Programs, Provider Training, Community Awareness Initiatives
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6984&type=smp
Which Growth Factors Are Influencing Chronic Disease Management Market Expansion?
The escalation in the number of older individuals, commonly referred to as the geriatric population (those aged 65 and above), is contributing significantly to the expansion of the chronic disease management market. Elderly individuals are the most likely to develop chronic diseases, which often results in a heightened need for healthcare services and long-lasting support systems. This, in turn, amplifies the demand for chronic disease management solutions. For instance, a report released by the World Health Organization (WHO), a Switzerland-based entity focused on global public health, predicted in October 2024 that by 2030, one out of every six people globally would be 60 or older. By 2050, this number is projected to reach 2.1 billion globally. Therefore, the growth of the aging population will inevitably stimulate the expansion of the chronic disease management market.
Who Are the Dominant Players Across Different Chronic Disease Management Market Segments?
Major companies operating in the chronic disease management market include Allscripts Healthcare Solutions Inc. (now known as Veradigm Inc. ), ScienceSoft USA Corporation, Siemens Healthcare Private Limited, Infosys Limited, MINES and Associates Inc., Biofourmis Care Solutions Pte. Ltd., i2i Systems Inc., Phytel Inc., Wellcentive Inc., TriZetto Corporation, Mediware Human & Social Services Inc., Pegasystems Inc., ZeOmega Inc., Cigniti Technologies Limited, Health Catalyst, Cedar Gate Technologies, Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management LLC, Casenet LLC, ExlServings Holdings Inc., cliexa Inc., Vivify Health Inc., WellSky, Alkeus Pharmaceuticals, Healthy. io, Immunic Inc., GlaxoSmithKline (GSK), GEOVAX INC., Bluebird Bio, Optum Inc., Omada Health
What Are the Latest Developing Trends in the Chronic Disease Management Market?
The emergence of technology is indeed a trending phenomenon within the chronic disease management market. Sophisticated tech such as artificial intelligence (AI) is now being utilized in managing chronic illnesses. This new approach allows medical practitioners to make significant progress towards early detection and improved patient results in conditions such as heart disease, cancer, and diabetes. For instance, Biofourmis, a Boston-based startup expertise in AI-driven virtual health care and digital medication, launched their new service-Biofourmis Care-in February 2022. This service is specifically designed to offer superior remote care for those dealing with chronic diseases. Their primary focus is to boost adherence to care recommendations by providers, identify recurring signs of clinical degradation, and enable early treatment implementations.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/chronic-disease-management-global-market-report
Which Geographic Regions Are Expected to Dominate the Chronic Disease Management Market in the Coming Years?
North America was the largest region in the chronic disease management market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic disease management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Chronic Disease Management Market?
2. What is the CAGR expected in the Chronic Disease Management Market?
3. What Are the Key Innovations Transforming the Chronic Disease Management Industry?
4. Which Region Is Leading the Chronic Disease Management Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Geriatric Population Growth As A Key Driver Of The Chronic Disease Management Market: A Key Driver Powering Chronic Disease Management Market Growth In 2025 here
News-ID: 3952762 • Views: …
More Releases from The Business Research Company

Rising Incidence of Dental Disorders Sparks Growth in the Tooth-Filling Material …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Tooth Filling Materials Market Through 2025?
In the past few years, the market size for tooth filling materials has experienced robust growth. Projected to rise from $1.82 billion in 2024 to $1.92 billion in 2025, it's set to journey at a compound…

2025-2034 Stress Tests Equipment Market Outlook: Key Drivers, Emerging Challenge …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Stress Tests Equipment Industry Market Size Be by 2025?
In recent years, the market for stress test equipment has seen robust growth. From a value of $2.99 billion in 2024, it is projected to increase to $3.19 billion in 2025, reflecting a compound annual growth rate…

2025 Positron Emission Tomography (PET) Scanners Industry Trends Report: Long-Te …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Positron Emission Tomography (PET) Scanners Market Size By 2025?
The market size for positron emission tomography (pet) scanners has been witnessing a steady increment in the past years. The market is expected to escalate from $1.51 billion in 2024 to $1.58 billion in 2025, registering…

Strategic Forecast for the Ostomy Devices Industry: Market Outlook 2025-2034
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Ostomy Devices Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the ostomy devices market has been consistently expanding. Projections show an increase from $2.8 billion in 2024 to $2.9 billion in 2025, maintaining a compound annual growth rate (CAGR) of 3.9%. The significant…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…